检索结果 - Raymond J. Hohl

  • Showing 1 - 18 results of 18
Refine Results
  1. 1
    Differential Effects of Monoterpenes and Lovastatin on RAS Processing

    Differential Effects of Monoterpenes and Lovastatin on RAS Processing 由 Raymond J. Hohl, Kriste A. Lewis

    出版 1995
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Consequences of Mevalonate Depletion

    Consequences of Mevalonate Depletion 由 Sarah A. Holstein, Christine Wohlford-Lenane, Raymond J. Hohl

    出版 2002
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Cancer and the Dopamine D<sub>2</sub>Receptor: A Pharmacological Perspective

    Cancer and the Dopamine D<sub>2</sub>Receptor: A Pharmacological Perspective 由 Jillian Weissenrieder, Jeffrey D. Neighbors, Richard B. Mailman, Raymond J. Hohl

    出版 2019
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  4. 4
    The Dopamine D&lt;sub&gt;2&lt;/sub&gt; Receptor Contributes to the Spheroid Formation Behavior of U87 Glioblastoma Cells

    The Dopamine D&lt;sub&gt;2&lt;/sub&gt; Receptor Contributes to the Spheroid Formation Behavior of U87 Glioblastoma Cells 由 Jillian Weissenrieder, J. Reed, Michelle V. Green, George‐Lucian Moldovan, Emily J. Koubek, Jeffrey D. Neighbors, Raymond J. Hohl

    出版 2019
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Phase II study of high‐dose fish oil capsules for patients with cancer‐related cachexia

    Phase II study of high‐dose fish oil capsules for patients with cancer‐related cachexia 由 C. Patrick Burns, Susan Halabi, Gerald H. Clamon, Ellen B. Kaplan, Raymond J. Hohl, James N. Atkins, Michael Schwartz, Brett A. Wagner, Electra Paskett

    出版 2004
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    VISTA is highly expressed on MDSCs and mediates an inhibition of T cell response in patients with AML

    VISTA is highly expressed on MDSCs and mediates an inhibition of T cell response in patients with AML 由 Liru Wang, Bei Jia, David F. Claxton, W. Christopher Ehmann, Witold B. Rybka, Shin Mineishi, Seema Naik, Muhammad Rizwan Khawaja, Jeff Sivik, Junyan Han, Raymond J. Hohl, Hong Zheng

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Brain cholesterol metabolism and Parkinson's disease

    Brain cholesterol metabolism and Parkinson's disease 由 Xuemei Huang, Nicholas W. Sterling, Guangwei Du, Dongxiao Sun, Christina Stetter, Lan Kong, Yusheng Zhu, Jeffrey D. Neighbors, Mechelle M. Lewis, Honglei Chen, Raymond J. Hohl, Richard B. Mailman

    出版 2019
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Bone marrow CD8 T cells express high frequency of PD-1 and exhibit reduced anti-leukemia response in newly diagnosed AML patients

    Bone marrow CD8 T cells express high frequency of PD-1 and exhibit reduced anti-leukemia response in newly diagnosed AML patients 由 Bei Jia, Liru Wang, David F. Claxton, W. Christopher Ehmann, Witold B. Rybka, Shin Mineishi, Syed Rizvi, Hiroko Shike, Michael G. Bayerl, Todd D. Schell, Raymond J. Hohl, Hong Zheng

    出版 2018
    获取全文
    Carta
    加到收藏夹
    Saved in:
  9. 9
    Blimp-1 impairs T cell function via upregulation of TIGIT and PD-1 in patients with acute myeloid leukemia

    Blimp-1 impairs T cell function via upregulation of TIGIT and PD-1 in patients with acute myeloid leukemia 由 Liuluan Zhu, Yaxian Kong, Jianhong Zhang, David F. Claxton, W. Christopher Ehmann, Witold B. Rybka, Neil Palmisiano, Ming Wang, Bei Jia, Michael G. Bayerl, Todd D. Schell, Raymond J. Hohl, Hui Zeng, Hong Zheng

    出版 2017
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    Phase II clinical trial of neoadjuvant trabectedin in patients with advanced localized myxoid liposarcoma

    Phase II clinical trial of neoadjuvant trabectedin in patients with advanced localized myxoid liposarcoma 由 Alessandro Gronchi, B. Bui, Sylvie Bonvalot, S. Pilotti, Stefano Ferrari, Peter Hohenberger, Raymond J. Hohl, George D. Demetri, Axel Le Cesne, Pilar Lardelli, I. Brao Pérez, Antonio Nieto, Juan Carlos Tercero, Vicente Alfaro, Elena Tamborini, Jean‐Yves Blay

    出版 2011
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    Eomes+T-betlow CD8+ T Cells Are Functionally Impaired and Are Associated with Poor Clinical Outcome in Patients with Acute Myeloid Leukemia

    Eomes+T-betlow CD8+ T Cells Are Functionally Impaired and Are Associated with Poor Clinical Outcome in Patients with Acute Myeloid Leukemia 由 Bei Jia, Chenchen Zhao, Kevin Rakszawski, David F. Claxton, W. Christopher Ehmann, Witold B. Rybka, Shin Mineishi, Ming Wang, Hiroko Shike, Michael G. Bayerl, Jeffrey Sivik, Todd D. Schell, Joseph J. Drabick, Raymond J. Hohl, Hong Zheng

    出版 2019
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    A phase I and pharmacokinetic study of irinotecan in patients with hepatic or renal dysfunction or with prior pelvic radiation: CALGB 9863

    A phase I and pharmacokinetic study of irinotecan in patients with hepatic or renal dysfunction or with prior pelvic radiation: CALGB 9863 由 Alan P. Venook, Colin Klein, Gini F. Fleming, Donna Hollis, Cynthia G. Leichman, Raymond J. Hohl, John C. Byrd, Daniel R. Budman, Miguel A. Villalona, John L. Marshall, Gary L. Rosner, Jacqueline Ramı́rez, Helen Kastrissios, Mark J. Ratain

    出版 2003
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    Post-transplant cyclophosphamide alters immune signatures and leads to impaired T cell reconstitution in allogeneic hematopoietic stem cell transplant

    Post-transplant cyclophosphamide alters immune signatures and leads to impaired T cell reconstitution in allogeneic hematopoietic stem cell transplant 由 Chenchen Zhao, Matthew Bartock, Bei Jia, Neal Shah, David F. Claxton, Baldeep Wirk, Kevin Rakszawski, Myles Nickolich, Seema Naik, Witold B. Rybka, W Christopher C. Ehmann, Raymond J. Hohl, Jessica Valentin, Michelle Bernas-Peterson, Emily M. Gerber, Michele Zimmerman, Joseph Mierski, Shin Mineishi, Hong Zheng

    出版 2022
    获取全文 获取全文
    Carta
    加到收藏夹
    Saved in:
  14. 14
    Phase I and Pharmacokinetic Study of Sorafenib in Patients With Hepatic or Renal Dysfunction: CALGB 60301

    Phase I and Pharmacokinetic Study of Sorafenib in Patients With Hepatic or Renal Dysfunction: CALGB 60301 由 Antonius A. Miller, Daryl J. Murry, Kouros Owzar, Donna Hollis, Erin B. Kennedy, Ghassan K. Abou‐Alfa, Apurva A. Desai, Jimmy J. Hwang, Miguel A. Villalona‐Calero, E. Claire Dees, Lionel D. Lewis, Marwan Fakih, Martin J. Edelman, Fred Millard, Richard C. Frank, Raymond J. Hohl, Mark J. Ratain

    出版 2009
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical-laboratory correlative trial

    Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical-laboratory correlative trial 由 Judith E. Karp, Jeffrey E. Lancet, Scott H. Kaufmann, David W. End, James R. Wright, Kees Bol, Ivan D. Horak, Michael L. Tidwell, Jane L. Liesveld, Timothy Kottke, Dawn Ange, Laxmi Narayana Buddharaju, Ivana Gojo, W. Edward Highsmith, R. T. Belly, Raymond J. Hohl, Mary Ellen Rybak, Alain Thibault, Joseph D. Rosenblatt

    出版 2001
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    A Phase 2 Cancer Chemoprevention Biomarker Trial of Isoflavone G-2535 (Genistein) in Presurgical Bladder Cancer Patients

    A Phase 2 Cancer Chemoprevention Biomarker Trial of Isoflavone G-2535 (Genistein) in Presurgical Bladder Cancer Patients 由 Edward M. Messing, Jason Gee, Daniel R. Saltzstein, KyungMann Kim, Anthony diSant'Agnese, Jill Kolesar, Linda S. Harris, Adrienne Faerber, Thomas C. Havighurst, Jay M. Young, Mitchell Efros, Robert H. Getzenberg, Marcia A. Wheeler, Joseph A. Tangrea, Howard L. Parnes, Margaret G. House, J. Erik Busby, Raymond J. Hohl, Howard H. Bailey

    出版 2012
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

    A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse 由 W.K. Alfred Yung, Robert E. Albright, Jeffrey J. Olson, Ruth K. Fredericks, Karen Fink, Michael D. Prados, M. Brada, A. Spence, Raymond J. Hohl, William Shapiro, Michael Glantz, H. S. Greenberg, Robert G. Selker, Nicholas A. Vick, R. Rampling, Henry S. Friedman, Peter C. Phillips∥, Janet Bruner, N C Yue, David Osoba, Sara Zaknoen, Victor A. Levin

    出版 2000
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  18. 18
    First-in-Human Phase I Clinical Trial of Pharmacologic Ascorbate Combined with Radiation and Temozolomide for Newly Diagnosed Glioblastoma

    First-in-Human Phase I Clinical Trial of Pharmacologic Ascorbate Combined with Radiation and Temozolomide for Newly Diagnosed Glioblastoma 由 Bryan G. Allen, Kellie L. Bodeker, Mark C. Smith, Varun Monga, Sonia Sandhu, Raymond J. Hohl, Thomas Carlisle, Heather A. Brown, Nancy Hollenbeck, Sandy Vollstedt, Jeremy D.W. Greenlee, Matthew A. Howard, Kranti A. Mapuskar, Steven N. Seyedin, Joseph M. Caster, Karra A. Jones, Joseph J. Cullen, Daniel Berg, Brett A. Wagner, Garry R. Buettner, M.J. Tennapel, Bruce A. Smith, Douglas R. Spitz, John M. Buatti

    出版 2019
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: